GGrantIndex
← Leaderboards

Andrew Eric Gelman

Washington University

$12,797,349
Attributed
$19,620,569
Total exposure
16
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,620,569 · 16

By mechanism

R01$13,334,959 · 5
P01$4,895,024 · 8
R61$655,076 · 1
R33$544,885 · 1
R21$190,625 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Lung

Research focus

LungLung TransplantationOrganSolidPathway InteractionsResponseGraft RejectionCellsLung DiseasesReportingLaboratoriesTransplant RecipientsLung AllograftPreventNeutrophilChronicTransplantationFunctional DisorderReperfusion InjuryMediatingPatternRisk FactorsPlayImmune

Grant awards (52)

Organ donor circadian clocks in transplantation acceptance$705,421
R01 · FY2025 · HL
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$694,901
R01 · FY2025 · HL
PET Tracer for Imaging of Lung Inflammation$668,671
R01 · FY2025 · HL
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation$544,885
R33 · FY2025 · HL
Targeting and imaging of inflammatory circuits in CLAD$312,031
P01 · FY2025 · AI · contact PI
Administrative Core$62,644
P01 · FY2025 · AI · contact PI
PET Tracer for Imaging of Lung Inflammation$673,682
R01 · FY2024 · HL
Mechanisms that Promote Chronic Lung Transplant Rejection$373,015
P01 · FY2024 · AI · contact PI
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation$283,671
R61 · FY2024 · HL
Administrative Core$78,751
P01 · FY2024 · AI · contact PI
PET Tracer for Imaging of Lung Inflammation$730,488
R01 · FY2023 · HL
Mechanisms that Promote Chronic Lung Transplant Rejection$375,912
P01 · FY2023 · AI · contact PI
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation$371,405
R61 · FY2023 · HL
Administrative Core$77,665
P01 · FY2023 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,808
R01 · FY2022 · HL
Mechanisms that Promote Chronic Lung Transplant Rejection$379,287
P01 · FY2022 · AI · contact PI
Administrative Core$78,750
P01 · FY2022 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,809
R01 · FY2021 · HL
Mechanisms that Promote Chronic Lung Transplant Rejection$386,852
P01 · FY2021 · AI · contact PI
Administrative Core$78,535
P01 · FY2021 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,808
R01 · FY2020 · HL
Mechanisms that Promote Chronic Lung Transplant Rejection$393,644
P01 · FY2020 · AI · contact PI
Administrative Core$78,729
P01 · FY2020 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$529,123
R01 · FY2019 · HL
The Role of Neutrophils in Regulating Lung Transplant Tolerance$354,041
P01 · FY2019 · AI · contact PI
Administrative Core$88,511
P01 · FY2019 · AI · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2018 · HL
The Role of Neutrophils in Regulating Lung Transplant Tolerance$356,342
P01 · FY2018 · AI · contact PI
Administrative Core$89,086
P01 · FY2018 · AI · contact PI
POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANT$698,863
R01 · FY2017 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2017 · HL
The Role of Neutrophils in Regulating Lung Transplant Tolerance$357,602
P01 · FY2017 · AI · contact PI
Administrative Core$89,400
P01 · FY2017 · AI · contact PI
POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANT$698,863
R01 · FY2016 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2016 · HL
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURY$380,000
R01 · FY2016 · HL · contact PI
The Role of Neutrophils in Regulating Lung Transplant Tolerance$358,567
P01 · FY2016 · AI · contact PI
MECHANISMS OF EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF LUNG ALLOGRAFT REJECTION$190,625
R21 · FY2016 · AI · contact PI
Administrative Core$89,641
P01 · FY2016 · AI · contact PI
POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANT$699,646
R01 · FY2015 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2015 · HL
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURY$374,300
R01 · FY2015 · HL · contact PI
The Role of Neutrophils in Regulating Lung Transplant Tolerance$366,000
P01 · FY2015 · AI · contact PI
Administrative Core$70,019
P01 · FY2015 · AI · contact PI
POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANT$709,330
R01 · FY2014 · HL · contact PI
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURY$372,400
R01 · FY2014 · HL · contact PI
GRANULOPOIESIS REGULATION IN LUNG GRAFT ISCHEMIA-REPERFUSION INJURY$361,760
R01 · FY2013 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$358,142
R01 · FY2013 · HL
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$376,200
R01 · FY2012 · HL
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2011 · HL
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2010 · HL
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2009 · HL